Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Moneysupermarket.Com Share News (MONY)
MONY Share
Price
MONY Share
News
MONY Share
Chat
MONY Share
Trades2,341
MONY
Live RNS1
MONY Share
Charts
MONY Level 2
Console
MONY Live
Share Price
MONY Broker
Ratings
MONY Directors
Deals
MONY Financial
Diary
MONY
Fundamentals
MONY Short
Positions3
MONY
Media
MONY Company
Research
MONY Company
Timeline4
Share Price Information for Moneysupermarket.Com (MONY)
Last checked at -
Last checked at 
Intraday Moneysupermarket.Com Share Chart
Friday broker round-up
BooHoo: Credit Suisse reiterates outperform with a target price of 370p.
888 Holdings: Peel Hunt reiterates buy with a target price of 215p.
Filtrona: Peel Hunt downgrades to reduce with a target price of 8,040p.
GVC: Peel Hunt reiterates buy with a target price of 1,030p.
Trifast: Shore Capital Markets downgrades to hold with a target price of 220p.
Moneysupermarket.com: Shore Capital Markets upgrades to buy.
Antofagasta: UBS upgrades to neutral with a target price of 850p.
RELX: Berenberg downgrades to hold with a target price of 2,100p.
Prudential: JP Morgan reiterates neutral with a target price of 1,425p.
Lancashire: UBS reiterates buy with a target price of 870p.
Frontier Developments: Berenberg reiterates buy with a target price of 1,800p.
Midwich Group: Berenberg reiterates buy with a target price of 670p.
Latest MONY News
- UK dividends calendar - next 7 days
1 May 2026 - Mony confident for year after "good growth" in first four months
30 Apr 2026 - LONDON BROKER RATINGS: Exane BNP initiates coverage; UBS cuts SSP
28 Apr 2026 - WINNERS & LOSERS: AO World backs view; B&M shares decline
10 Apr 2026 - WINNERS & LOSERS: Metlen Energy takes hit from annual results delay
27 Mar 2026 - Jefferies upgrades Mony to 'buy', says AI-driven fears are misplaced
27 Mar 2026 - LONDON BROKER RATINGS: BofA raises Berkeley; UBS raises Savills
27 Mar 2026 - LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review
27 Mar 2026
Related News
LONDON MARKET CLOSE: FTSE 100 struggles despite US-Iran deal progress
(Alliance News) - The FTSE 100 gave back early gains in the wake of the US-Iran peace deal on a mixed day for stocks in London on Monday.
LONDON MARKET MIDDAY: FTSE pares gains as US-Iran deal lifts sentiment
(Alliance News) - Stock prices in London surrendered much of their early advance by midday on Monday, although remained in positive territory as inves...
WINNERS & LOSERS: Mining and travel stocks soar as Iran deal hits oil
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday.
Moneysupermarket.Com News
Mony confident for year after "good growth" in first four months
(Alliance News) - Mony Group PLC on Thursday reiterated its full-year guidance after a "solid" start to 2026.
LONDON BROKER RATINGS: Exane BNP initiates coverage; UBS cuts SSP
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
WINNERS & LOSERS: AO World backs view; B&M shares decline
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.
WINNERS & LOSERS: Metlen Energy takes hit from annual results delay
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.
Jefferies upgrades Mony to 'buy', says AI-driven fears are misplaced
(Sharecast News) - Jefferies upgraded Mony Group to 'buy' from 'hold' on Friday and lifted the price target to 230p from 205p, citing an attractive en...
LONDON BROKER RATINGS: BofA raises Berkeley; UBS raises Savills
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday day:
LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review
(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regu...
Follow the stocks
